SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0000950170-23-039079
Filing Date
2023-08-07
Accepted
2023-08-07 16:15:35
Documents
1
Period of Report
2023-06-30
Effectiveness Date
2023-08-07

Document Format Files

Seq Description Document Type Size
1 NT 10-Q form_12b-25_q2.htm NT 10-Q 30995
  Complete submission text file 0000950170-23-039079.txt   32129
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 231147813
SIC: 2836 Biological Products, (No Diagnostic Substances)